Significance: Our knowledge of the functions required by extracellular bacterial pathogens to grow in host tissues is still limited. Most available information refers to studies conducted under laboratory growth conditions that mimic host environments but exclude the influence of the host immune system. Tissue dual RNA sequencing allows simultaneous transcript profiling of a pathogen and its infected host. This sensitive approach led to the identification of host immune responses and virulence-relevant bacterial functions that were not previously reported in the context of a Yersinia infection. Application of this tool will allow transcript profiling of other pathogens to unravel concealed gene functions that are crucial for survival in different host niches and will improve identification of potential drug targets.
Resistance of important bacterial pathogens to common antimicrobial therapies and the emergence of multidrug-resistant bacteria are increasing at an alarming rate and constitute one of our greatest challenges in the combat of bacterial infection and accompanied diseases. The current shortage of effective drugs, lack of successful prevention measures and only a few new antibiotics in the clinical pipeline demand the development of novel treatment options and alternative antimicrobial therapies. Our increasing understanding of bacterial virulence strategies and the induced molecular pathways of the infectious disease provides novel opportunities to target and interfere with crucial pathogenicity factors or virulence-associated traits of the bacteria while bypassing the evolutionary pressure on the bacterium to develop resistance. In the past decade, numerous new bacterial targets for anti-virulence therapies have been identified, and structure-based tailoring of intervention strategies and screening assays for small-molecule inhibitors of such pathways were successfully established. In this chapter, we will take a closer look at the bacterial virulence-related factors and processes that present promising targets for anti-virulence therapies, recently discovered inhibitory substances and their promises and discuss the challenges, and problems that have to be faced.
Expression of all Yersinia pathogenicity factors encoded on the virulence plasmid, including the yop effector and the ysc type III secretion genes, is controlled by the transcriptional activator LcrF in response to temperature. Here, we show that a protein- and RNA-dependent hierarchy of thermosensors induce LcrF synthesis at body temperature. Thermally regulated transcription of lcrF is modest and mediated by the thermo-sensitive modulator YmoA, which represses transcription from a single promoter located far upstream of the yscW-lcrF operon at moderate temperatures. The transcriptional response is complemented by a second layer of temperature-control induced by a unique cis-acting RNA element located within the intergenic region of the yscW-lcrF transcript. Structure probing demonstrated that this region forms a secondary structure composed of two stemloops at 25°C. The second hairpin sequesters the lcrF ribosomal binding site by a stretch of four uracils. Opening of this structure was favored at 37°C and permitted ribosome binding at host body temperature. Our study further provides experimental evidence for the biological relevance of an RNA thermometer in an animal model. Following oral infections in mice, we found that two different Y. pseudotuberculosis patient isolates expressing a stabilized thermometer variant were strongly reduced in their ability to disseminate into the Peyer's patches, liver and spleen and have fully lost their lethality. Intriguingly, Yersinia strains with a destabilized version of the thermosensor were attenuated or exhibited a similar, but not a higher mortality. This illustrates that the RNA thermometer is the decisive control element providing just the appropriate amounts of LcrF protein for optimal infection efficiency. Many important virulence genes remain silent at moderate temperatures in external environments and are rapidly and strongly induced by a sudden temperature upshift sensed upon host entry. Thermal activation of virulence gene transcription is frequently described, but post-transcriptional control mechanisms implicated in temperature-sensing and induction of virulence factor synthesis are less evident. Here, we present a novel two-layer regulatory system implicating a protein- and an RNA-dependent thermosensor controlling synthesis of the most crucial virulence activator LcrF (VirF) of pathogenic yersiniae. In this case, moderate function of a thermosensitive gene silencer is coupled with the more dominant action of a unique intergenic two-stemloop RNA thermometer. Thermally-induced conformational changes in this RNA element control the transition between a ‘closed’ and an ‘open’ structure which allows ribosome access and translation of the lcrF/virF transcript. This mechanism guarantees optimal virulence factor production during the course of an infection, ideal for survival and multiplication of yersiniae within their warm-blooded hosts. The hierarchical concept combining two temperature-sensing modules constitutes a new example of how bacterial pathogens use complementing strategies to allow rapid, energetically cheap and fine-tuned adaptation of their virulence traits.
8 June 2010 in Applied Microbiology and Biotechnology